Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
异源性 cAd3-Ebola 和 MVA-EbolaZ 疫苗在美国和乌干达的 1/1b 期临床试验中显示出安全性和免疫原性。
期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-024-00833-z
Happe, Myra; Hofstetter, Amelia R; Wang, Jing; Yamshchikov, Galina V; Holman, LaSonji A; Novik, Laura; Strom, Larisa; Kiweewa, Francis; Wakabi, Salim; Millard, Monica; Kelley, Colleen F; Kabbani, Sarah; Edupuganti, Srilatha; Beck, Allison; Kaltovich, Florence; Murray, Tamar; Tsukerman, Susanna; Carr, Derick; Ashman, Carl; Stanley, Daphne A; Ploquin, Aurélie; Bailer, Robert T; Schwartz, Richard; Cham, Fatim; Tindikahwa, Allan; Hu, Zonghui; Gordon, Ingelise J; Rouphael, Nadine; Houser, Katherine V; Coates, Emily E; Graham, Barney S; Koup, Richard A; Mascola, John R; Sullivan, Nancy J; Robb, Merlin L; Ake, Julie A; Lyke, Kirsten E; Mulligan, Mark J; Ledgerwood, Julie E; Kibuuka, Hannah